Yaghmour 2012.

Notes

Title: PET‐negative at 2, 3 or 4 cycles of ABVD in Hodgkin's lymphoma is still good. (Conference abstract) Aim To assess the prognostic value of anytime negative PET scan in the course of first line treatment in individuals with HL receiving ABVD Study design Retrospective Country/treatment centre(s) USA (Henry Ford Health System, Detroit MI) Number of included participants 32 Inclusion criteria Newly diagnosed HL Exclusion criteria Not reported Treatment ABVD Primary outcome measure(s) Overall survival